NASDAQ:CNSP

Cns Pharmaceuticals Stock Predictions

etoro logo Buy CNSP
*Your capital is at risk
$5.24
+0.320 (+6.50%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

CNSP Prediction Chart

CNSP Predictions History

Latest community submissions for CNSP.
Predictor Target Session Target Price Result Direction Accuracy Score
Feb 12, 2025 $0.107 -98.06% $0.104 V 97.05% 1
Feb 12, 2025 Bullish $0.104 X 0
Jan 21, 2025 $0.108 -97.88% $0.106 X 97.84% 1
Jan 21, 2025 $0.106 -97.93% $0.106 X 99.96% 10
Jan 21, 2025 Bullish $0.106 X 1
Jan 17, 2025 $0.115 -97.89% $0.102 X 87.19% 0
Jan 17, 2025 $0.113 -97.93% $0.102 X 89.45% 0
Jan 17, 2025 $0.110 -97.98% $0.102 X 92.05% 0
Jan 17, 2025 Bullish $0.102 X 0
Jul 31, 2024 $0.553 -97.30% $0.317 X 25.45% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for CNSP with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT CNS PHARMACEUTICALS, INC.
CNS Pharmaceuticals
CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, engages in the development of anti-cancer drug candidates for the treatment of brain and central nervous system tumors. The company's lead drug candidate is Berubicin, an anthracycline that is in Phase I and II clinical trials that is used for the treatment of glioblastoma multiforme. It has license agreements with Houston Pharmaceuticals, Inc. and The University of Texas M.D. Anderson...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE